FDA nominee faces scrutiny over experience and vaccine policies

Heidi Overton, a White House aide nominated to lead the Food and Drug Administration, faces scrutiny over her management experience and role in drafting executive orders affecting childhood vaccinations and glyphosate use. Senate committee Chairman Bill Cassidy has expressed strong concerns ahead of her confirmation hearing.

Louisiana officials and families say the FDA leadership change could affect food inspections, seafood imports, public health and supplies of specialized medical nutrition. The White House says Overton presented policies sought by President Donald Trump, who has praised her work.

Read the full story at nola.com.